Search - tctmd.com

Displaying 621 - 640 of 673

Sort: Relevancy | Date

News Conference News

Stem Cells Derived from Body Fat Improved Certain Cardiac Outcomes

November 06, 2011

News Conference News

Prasugrel, Ticagrelor Reduced Incidence of Stent Thrombosis

November 06, 2011

News Conference News

DES Noninferior for Survival Compared with BMS in STEMI

November 06, 2011

News Industry News

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

November 04, 2011

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Daily News

Delayed Stenting Optimizes Microvascular Perfusion in STEMI Patients

October 26, 2011

News Daily News

In-hospital Bleeding after Primary PCI Increases Long-term Mortality

October 10, 2011

News Daily News

Pre-PCI Hydration Feasible, Reduces Kidney Damage in STEMI Patients

Caitlin E. Cox

October 07, 2011

News Daily News

STEMI Patients Benefit From Clopidogrel Given Prior to PCI Center

Caitlin E. Cox

September 28, 2011

News Daily News

Novel Peptide During Primary PCI Helps Limit Reperfusion Injury

Caitlin E. Cox

September 23, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

Jason Kahn

September 06, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

Long-term Antiplatelet Therapy: All Risk, No Benefit

August 30, 2011

News Conference News

New-Generation DES Reduce Restenosis, Stent Thrombosis

August 29, 2011

News Daily News

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

Leah Lawrence

August 23, 2011

News Daily News

Poor Association Between Stent Thrombosis, Platelet Function Tests

L.A. McKeown

July 26, 2011

News Daily News

Delayed Primary PCI Generally Superior to Early Fibrinolysis for STEMI

July 25, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

Advertisement

Stem Cells Derived from Body Fat Improved Certain Cardiac Outcomes

Prasugrel, Ticagrelor Reduced Incidence of Stent Thrombosis

DES Noninferior for Survival Compared with BMS in STEMI

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

Delayed Stenting Optimizes Microvascular Perfusion in STEMI Patients

In-hospital Bleeding after Primary PCI Increases Long-term Mortality

Pre-PCI Hydration Feasible, Reduces Kidney Damage in STEMI Patients

STEMI Patients Benefit From Clopidogrel Given Prior to PCI Center

Novel Peptide During Primary PCI Helps Limit Reperfusion Injury

ESC Congress 2011: Drugs, Devices Work Together

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

Long-term Antiplatelet Therapy: All Risk, No Benefit

New-Generation DES Reduce Restenosis, Stent Thrombosis

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

Poor Association Between Stent Thrombosis, Platelet Function Tests

Delayed Primary PCI Generally Superior to Early Fibrinolysis for STEMI

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Ticagrelor Gains FDA Approval for Use in ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content